Peter LLEWELLYN-DAVIES Chief Executive Officer, APEIRON Biologics AG, Vienna
CV
| Education | |
| Business Studies, University of London | |
| Marketing, St. Galler Business School, St. Gallen | |
| Fellowship of the London Institute of Banking and Finance | |
| 1996-2003 | Managing Director, Süd-Chemie AG, Munich |
| 2003-2005 | Executive Director, Müller Dairy UK Ltd. |
| 2006-2012 | Chief Financial Officer, Wilex AG, Munich |
| 2012-2016 | Chief Financial Officer and Chief Business Officer, Medigene AG, Munich |
| since 2006 | Founder and Chief Executive Officer, Accellerate Partners, London and Munich |
| since 2016 | Non-Executive Director and Chairman of Audit Committee, Shield Therapeutics PLC, London |
| since 2017 | Member of the Supervisory Board and Chairman of Audit Committee, Sygnis AG, Heidelberg |
| Chief Financial Officer and Chief Business Officer, APEIRON Biologics AG, Vienna | |
| since 2018 | Chief Executive Officer, APEIRON Biologics AG, Vienna |
